Evidence map›Paper›PMID 42014142›Full record

ArticleBMJ open2026

HIV care attrition among pregnant and postpartum adolescent girls and young women living with HIV in Tanzania: findings from a prospective cohort study.

Roseline F Urrio, Lameck Machumi, Helga Naburi, Michael J Mahande, Charles Festo, Andrew Mganga, Daima Machang'u, Brenda Simba, Hellen Siril, Theodora Mbunda and 9 more

Abstract read
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Roseline F UrrioManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of rurio@mdh.or.tz.ORCID http://orcid.org/0000-0002-1413-7900
Lameck MachumiManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Helga NaburiDepartment of Pediatric and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Michael J MahandeManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Charles FestoManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Andrew MgangaManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Daima Machang'uManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Brenda SimbaManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Hellen SirilManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Theodora MbundaManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Wilhellmuss MaukaManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.
Ayoub KibaoOffice of the Regional Administrative Secretary, Dar es Salaam, Tanzania, United Republic of.
Michael MsangiMinistry of Health, Dar es Salaam, Tanzania, United Republic of.
Elin C LarssonDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5189-808X
Gunnel BiberfeldDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.
Charles KilewoDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
Anna E KågestenDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-5458-8319
Anna Mia EkströmDepartment of Global Public Health, Karolinska Institute, Stockholm, Sweden.
Goodluck Willey LyatuuManagement and Development for Health, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0003-0779-5515

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo examine HIV care attrition patterns and risk factors among adolescent girls and young women (AGYW) enrolled in prevention of mother-to-child transmission of HIV (PMTCT) services in Tanzania.

designProspective cohort study.

settingThe study was conducted in three regions of Tanzania: Kagera, Tabora and Dar es Salaam across 543 public and private health facilities.

participantsA total of 10 147 pregnant and postpartum AGYW living with HIV attending PMTCT services between 1 January 2018 and 31 December 2020 were included in this study and followed prospectively until they were censored at the last appointment date or 31 December 2023, whichever was earlier. PRIMARY OUTCOME MEASURES: The primary outcome was time to HIV care attrition, defined as death, discontinuation of antiretroviral treatment (ART) or loss to follow-up (LTFU). LTFU was defined as failure to attend a scheduled clinic appointment and being absent from care for ≥90 consecutive days following a missed appointment among non-transfers. Kaplan-Meier analyses were used to estimate time to first attrition. The Anderson-Gill proportional hazard model estimated the risk factors for repeated care interruptions, adjusted for baseline characteristics and stratified by ART status at PMTCT enrolment.

resultsA total of 3259 attrition events were observed, of which 79% occurred within the first year, with the median time to first attrition of 4 months (IQR: 1-8), 96.3% were due to LTFU. Over two-thirds of first-year attrition occurred among AGYW newly started on ART at PMTCT enrolment, who had more than twice the attrition rate of those already on ART (28.6 vs 11.2 per 100-person-years). Of AGYW lost to follow-up, 44.8% returned to care and 20.9% experienced subsequent attrition. Among AGYW new on ART, attrition was higher in those enrolled late in their third trimester (adjusted HR (aHR) 1.20; 95% CI 1.01 to 1.42) versus those in the first trimester and lower during the postpartum period (aHR 0.58; 95% CI 0.43 to 0.79). In AGYW already on ART, attrition rate was higher among adolescents 18-19 years (aHR 1.37; 95% CI 1.13 to 1.66) and those enrolled late; during the second (aHR 1.41; 95% CI 1.16 to 1.72) and third trimesters (aHR 1.57; 95% CI 1.23 to 2.00) or post partum (aHR 1.36; 95% CI 1.09 to 1.70) compared with the first trimester. AGYW with early-stage HIV, on second-line regimens and attending facilities with fewer AGYW, had a lower attrition rate in contrast to comparison groups.

conclusionAGYW newly started on ART at PMTCT enrolment are more likely to have early and recurring dropout. Given the cyclical nature of HIV care engagement, tailored and repeated interventions are needed to support continuous retention and re-engagement for pregnant and postpartum AGYW with HIV.

Indexed as

Anti-HIV AgentsHIV InfectionsInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdolescentFemaleHumansLost to Follow-UpPostpartum PeriodPregnancyProspective StudiesRisk FactorsTanzaniaYoung AdultAnti-HIV AgentsAdolescentHIV & AIDSPatient-Centered CarePostpartum WomenPregnancyPublic health

Identifiers

PMID42014142
PMCPMC13110532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.